Back to search
FDAFDA · Food and drugs·Recall number D-0325-2020

Motion Sickness Strips (meclizine hydrochloride) 25 mg strips, 8-count box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501, NDC 69842-288-01. UPC 5042849946

Published November 20, 2019 · Recall initiated: October 1, 2019

Summary

FDA records drug Class III recall D-0325-2020, published November 20, 2019 and initiated October 1, 2019. Recalling firm: Sato Pharmaceutical Inc.; Status: Terminated; Reported quantity: 39,504 units; Lot: Lot #: AXTK, AXAK, AXZK, AXNK, AXBK, AXLK, AXPK, AXCK, Exp. Date Nov 2021. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Sato Pharmaceutical Inc.
Distributor
Nationwide within the United States, Guam and Saipan
Lot
Lot #: AXTK, AXAK, AXZK, AXNK, AXBK, AXLK, AXPK, AXCK, Exp. Date Nov 2021
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Motion Sickness Strips (meclizine hydrochloride) 25 mg strips, 8-count box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501, NDC 69842-288-01. UPC 5042849946 recalled?

Yes. FDA published recall D-0325-2020 on November 20, 2019. Reported hazard: Subpotent Drug

What should I do if I have this product?

Voluntary: Firm initiated · Letter